glycine has been researched along with Dyslipidemias in 4 studies
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Muraglitazar is a non-thiazolidinedione, oxybenzylglycine dual PPARalpha/gamma agonist that is in advanced clinical development for the treatment of type 2 diabetes and its associated dyslipidemia." | 6.43 | Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia. ( Cox, SL, 2005) |
| "Muraglitazar is a non-thiazolidinedione, oxybenzylglycine dual PPARalpha/gamma agonist that is in advanced clinical development for the treatment of type 2 diabetes and its associated dyslipidemia." | 2.43 | Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia. ( Cox, SL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handzlik, MK | 1 |
| Gengatharan, JM | 1 |
| Frizzi, KE | 1 |
| McGregor, GH | 1 |
| Martino, C | 1 |
| Rahman, G | 1 |
| Gonzalez, A | 1 |
| Moreno, AM | 1 |
| Green, CR | 1 |
| Guernsey, LS | 1 |
| Lin, T | 1 |
| Tseng, P | 1 |
| Ideguchi, Y | 1 |
| Fallon, RJ | 1 |
| Chaix, A | 1 |
| Panda, S | 1 |
| Mali, P | 1 |
| Wallace, M | 1 |
| Knight, R | 1 |
| Gantner, ML | 1 |
| Calcutt, NA | 1 |
| Metallo, CM | 1 |
| Venkatesh, R | 1 |
| Srinivasan, K | 1 |
| Singh, SA | 1 |
| Yue, JT | 1 |
| Mighiu, PI | 1 |
| Naples, M | 1 |
| Adeli, K | 1 |
| Lam, TK | 1 |
| Cox, SL | 1 |
1 review available for glycine and Dyslipidemias
| Article | Year |
|---|---|
Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia.
Topics: Adult; Aged; Animals; Area Under Curve; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Th | 2005 |
3 other studies available for glycine and Dyslipidemias
| Article | Year |
|---|---|
Insulin-regulated serine and lipid metabolism drive peripheral neuropathy.
Topics: Adiposity; Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Dyslipidemias; Glycine; Insulin | 2023 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseas | 2017 |
Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats.
Topics: Adiponectin; Animals; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Dietary Fats; Dyslipidemias; Fat | 2012 |